医薬品添加剤の市場規模、シェア、成長分析、製品タイプ別、機能性別、製剤別、供給源別、エンドユーザー別、地域別 - 産業予測 2025～2032年

医薬品添加剤の世界市場規模は2023年に91億米ドルと評価され、2024年の96億3,000万米ドルから2032年には151億2,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは5.8%で成長する見通しです。

医薬品添加剤市場は、革新的な医薬品に対する需要の高まりとドラッグデリバリー技術の進歩によって大きく成長する見通しです。新薬開発への投資の増加とジェネリック医薬品の需要急増は、賦形剤メーカーに十分なビジネスチャンスをもたらします。さらに、医薬品製造活動の世界の拡大は、市場の見通しをさらに高めると予想されます。生物学的製剤の販売拡大により、特殊な賦形剤の需要が高まる可能性が高いです。しかし、製造コストの高騰、厳しい規制、原料供給の変動、代替品との競合といった課題は、市場の進展を妨げる可能性があります。北米とアジア太平洋地域が医薬品添加剤の支配的な市場であり続けると予測され、これらの地域における今後数年間の堅調な商業的可能性を示しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢

医薬品添加剤市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• 有機化学物質
  • 炭水化物
  • 糖類
  • デンプン
  • セルロースおよび誘導体
  • 石油化学製品
  • グリコール
  • ポビドン
  • 鉱物炭化水素
  • タンパク質
  • ゼラチン
  • アルブミン
• 無機化学品
  • リン酸カルシウム
  • 炭酸カルシウム
  • ステアリン酸マグネシウム
  • 塩化ナトリウム
  • 二酸化ケイ素
• その他
  • 油脂化学品
  • 天然賦形剤

医薬品添加剤市場規模：機能性別& CAGR（2025-2032）

• 市場概要
• バインダー
• 充填剤/希釈剤
• 崩壊剤
• コーティング剤
• 潤滑剤
• 防腐剤
• 香料と甘味料
• 着色剤
• 溶剤
• その他

医薬品添加剤市場規模：製剤別& CAGR（2025-2032）

• 市場概要
• 経口製剤
  • タブレット
  • カプセル
  • 粉末
  • シロップ
• 局所製剤
  • クリーム
  • 軟膏
  • ゲル
• 非経口製剤
  • 注射
  • 点滴
• 吸入製剤
  • ドライパウダー吸入器（DPI）
  • 定量噴霧式吸入器（MDI）
• 点眼薬
• 鼻腔製剤
• 坐薬

医薬品添加剤市場規模：供給源別& CAGR（2025-2032）

• 市場概要
• 天然
  • 植物由来
  • 動物由来
• 合成
  • 完全合成
  • 半合成

医薬品添加剤市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 製薬会社
• バイオ医薬品企業
• 契約製造組織（CMO）
• 契約調査機関（CRO）

医薬品添加剤市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Evonik Industries AG-Germany
• Ashland Global Holdings Inc.-USA
• International Flavors & Fragrances Inc.-USA
• Roquette Freres-France
• Fuji Chemical Industries Co., Ltd.-Japan
• Wacker Chemie AG-Germany
• MEGGLE GmbH & Co. KG-Germany
• Key Developments
• Biogrund GmbH-Germany
• Nitika Pharmaceutical Specialties Pvt. Ltd.-India
• J.M. Huber Corporation-USA
• Kerry Group plc-Ireland
• Colorcon Inc.-USA
• Merck KGaA-Germany
• DFE Pharma-Germany
• Finar Limited-India
• Corel Pharma Chem-India
• Gattefosse-France
• BASF SE-Germany
• DowDuPont Inc.-USA

結論と提言

Global Pharmaceutical Excipients Market size was valued at USD 9.1 billion in 2023 and is poised to grow from USD 9.63 billion in 2024 to USD 15.12 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The pharmaceutical excipients market is poised for significant growth driven by rising demand for innovative drugs and advancements in drug delivery technologies. Increased investments in novel drug development and a surging demand for generic medications present ample opportunities for excipient manufacturers. Additionally, the global expansion of pharmaceutical manufacturing activities is expected to further enhance market prospects. The growing sales of biologics will likely boost demand for specialized excipients. However, challenges such as high manufacturing costs, stringent regulations, raw material supply fluctuations, and competition from alternatives may hinder market progress. North America and the Asia Pacific regions are projected to remain the dominant markets for pharmaceutical excipients, indicating robust commercial potential in these areas in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Excipients market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pharmaceutical Excipients Market Segments Analysis

Global Pharmaceutical Excipients Market is segmented by Product Type, Functionality, Formulation, Source, End User and region. Based on Product Type, the market is segmented into Organic Chemicals, Inorganic Chemicals and Others. Based on Functionality, the market is segmented into Binders, Fillers/Diluents, Disintegrants, Coating Agents, Lubricants, Preservatives, Flavors and Sweeteners, Coloring Agents, Solvents and Others. Based on Formulation, the market is segmented into Oral Formulations, Topical Formulations, Parenteral Formulations, Inhalation Formulations, Ophthalmic Formulations, Nasal Formulations and Suppositories. Based on Source, the market is segmented into Natural and Synthetic. Based on End User, the market is segmented into Pharmaceutical Companies, Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pharmaceutical Excipients Market

The escalating costs of drugs and pharmaceuticals globally have sparked a significant surge in the demand for generic medicines. This trend is fueled by a rising focus on enhancing healthcare accessibility and lowering overall healthcare expenses. As a result, the market for generic medicines is expected to see substantial growth, which, in turn, will positively influence the development of the pharmaceutical excipients market. The increasing popularity of generic alternatives is driving innovation and competition, further propelling advancements within the excipients sector, making it an essential component of the pharmaceutical manufacturing process as the industry adapts to these market dynamics.

Restraints in the Global Pharmaceutical Excipients Market

The Global Pharmaceutical Excipients market faces significant restraints primarily due to the high research and development costs associated with excipient formulation. The intricate development process necessitates extensive investment throughout the entire product lifecycle, which can elevate overall expenses. Additionally, the growing reliance on advanced manufacturing equipment further contributes to these elevated production costs. As a result, this combination of high development and manufacturing expenses is likely to hinder sales growth in the pharmaceutical excipients sector in the foreseeable future, posing challenges for market expansion and profitability.

Market Trends of the Global Pharmaceutical Excipients Market

The Global Pharmaceutical Excipients market is witnessing a significant trend towards the incorporation of natural and biodegradable ingredients. As consumers increasingly gravitate towards wellness and sustainability, there is a rising demand for drug formulations that utilize natural excipients, steering away from traditional chemical-based alternatives. This shift is driven by a growing demographic that prioritizes health-conscious choices and seeks transparency in product formulations. Consequently, pharmaceutical excipient manufacturers are presented with lucrative opportunities to innovate and expand their product lines by integrating eco-friendly components, thereby aligning with consumer preferences and contributing to the overall growth of this dynamic market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Pharmaceutical Excipients Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Organic Chemicals
  • Carbohydrates
  • Sugars
  • Starches
  • Cellulose and Derivatives
  • Petrochemicals
  • Glycols
  • Povidone
  • Mineral Hydrocarbons
  • Proteins
  • Gelatin
  • Albumin
• Inorganic Chemicals
  • Calcium Phosphates
  • Calcium Carbonate
  • Magnesium Stearate
  • Sodium Chloride
  • Silicon Dioxide
• Others
  • Oleochemicals
  • Natural Excipients

Global Pharmaceutical Excipients Market Size by Functionality & CAGR (2025-2032)

• Market Overview
• Binders
• Fillers/Diluents
• Disintegrants
• Coating Agents
• Lubricants
• Preservatives
• Flavors and Sweeteners
• Coloring Agents
• Solvents
• Others

Global Pharmaceutical Excipients Market Size by Formulation & CAGR (2025-2032)

• Market Overview
• Oral Formulations
  • Tablets
  • Capsules
  • Powders
  • Syrups
• Topical Formulations
  • Creams
  • Ointments
  • Gels
• Parenteral Formulations
  • Injections
  • IV Infusions
• Inhalation Formulations
  • Dry Powder Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
• Ophthalmic Formulations
• Nasal Formulations
• Suppositories

Global Pharmaceutical Excipients Market Size by Source & CAGR (2025-2032)

• Market Overview
• Natural
  • Plant-based
  • Animal-based
• Synthetic
  • Fully synthetic
  • Semi-synthetic

Global Pharmaceutical Excipients Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Contract Research Organizations (CROs)

Global Pharmaceutical Excipients Market Size & CAGR (2025-2032)

• North America (Product Type, Functionality, Formulation, Source, End User)
  • US
  • Canada
• Europe (Product Type, Functionality, Formulation, Source, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Functionality, Formulation, Source, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Functionality, Formulation, Source, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Functionality, Formulation, Source, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Evonik Industries AG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ashland Global Holdings Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• International Flavors & Fragrances Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roquette Freres - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Chemical Industries Co., Ltd. - Japan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wacker Chemie AG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEGGLE GmbH & Co. KG - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Biogrund GmbH - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nitika Pharmaceutical Specialties Pvt. Ltd. - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J.M. Huber Corporation - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerry Group plc - Ireland
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DFE Pharma - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Finar Limited - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corel Pharma Chem - India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gattefosse - France
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE - Germany
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DowDuPont Inc. - USA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations